Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...
GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
The gut microbiome plays a crucial role in cancer development and progression, by influencing the host immune system and metabolism. Dysbiosis, or a disruption in the balance of the host gut ...
Right now, there are 70 early-phase trials open at FCS’ Sarasota location targeting a variety of types of cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results